Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 29, 2025: USD 181.72 M

Haemonetics Corporation Operating Cash Flow is USD 181.72 M for the Trailing 12 Months (TTM) ending March 29, 2025, a -0.01% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 181.75 M, a -33.44% change year over year.
  • Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 273.06 M, a 58.51% change year over year.
  • Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending April 02, 2022 was USD 172.26 M, a 58.32% change year over year.
  • Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending April 03, 2021 was USD 108.81 M, a -31.23% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities